Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh July 18, 2023Kalyn DabbsPress Releases Latest license creates a comprehensive panel of gene therapies exclusively licensed by Genprex for the Company’s diabetes gene therapy program Read More